Genetic variation in the vitamin d pathway in relation to risk of prostate cancer-results from the breast and prostate cancer cohort consortium

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 4, 2013, Pages 688-696

  Mondul, Alison M ^a   Shui, Irene M ^b   Yu, Kai ^a   Travis, Ruth C ⁱ   Stevens, Victoria L ^j   Campa, Daniele ^k,l   Schumacher, Frederick R ⁿ   Ziegler, Regina G ^a   Bueno De Mesquita, H Bas ^o,p   Berndt, Sonja ^a   Crawford, E D ^q   Gapstur, Susan M ^j   Gaziano, J Michael ^d,e,f,h   Giovannucci, Edward ^b,c,g   Haiman, Christopher A ⁿ   Henderson, Brian E ⁿ   Hunter, David J ^b,c,g   Johansson, Mattias ^r   Key, Timothy J ⁱ   Marchand, Loïc Le ^s   Lindström, Sara ^b   McCullough, Marjorie L ^j   Navarro, Carmen ^t,u   Overvad, Kim ^v,w   Palli, Domenico ^m   Purdue, Mark ^a   Stampfer, Meir J ^b,c,g   Weinstein, Stephanie J ^a   Willett, Walter C ^b,c,g   Yeager, Meredith ^a   Chanock, Stephen J ^a   Trichopoulos, Dimitrios ^b   Kolonel, Laurence N ^s   Kraft, Peter ^b   Albanes, Demetrius ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b Departments of Epidemiology and Biostatistics   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d Division of Preventive Medicine   (United States)

^e Divisions of Aging ^*  (United States)

^f Divisions of Cardiovascular Diseases   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h VA BOSTON HEALTHCARE SYSTEM   (United States)

ⁱ UNIVERSITY OF OXFORD   (United Kingdom)

^j AMERICAN CANCER SOCIETY   (United States)

^k GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^l UNIVERSITY OF PISA   (Italy)

^m CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

ⁿ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^o NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^p UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^q UNIVERSITY OF COLORADO HOSPITAL   (United States)

^r INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^s UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^t CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^u DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^v AARHUS UNIVERSITY   (Denmark)

^w AARHUS UNIVERSITY HOSPITAL   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D;

AGED; ALLELE; ARTICLE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY HISTORY; GENE LOCATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

AGED; CASE-CONTROL STUDIES; CHOLESTANETRIOL 26-MONOOXYGENASE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; NEOPLASM GRADING; NEOPLASM STAGING; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK FACTORS; STEROID HYDROXYLASES; TUMOR MARKERS, BIOLOGICAL; VITAMIN D;

EID: 84876557954     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0007-T     Document Type: Article

References (28)

1. Bouillon R, Eelen G, Verlinden L,Mathieu C, Carmeliet G, Verstuyf A. Vitamin D and cancer. J Steroid Biochem Mol Biol 2006;102: 156-62. (Pubitemid 44781185)
2. Holick MF. Vitamin D: its role in cancer prevention and treatment. Prog Biophys Mol Biol 2006;92:49-59. (Pubitemid 43831958)
3. Fleet JC. Molecular actions of vitamin D contributing to cancer prevention. Mol Aspects Med 2008;29:388-96.
4. Yin L, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis of longitudinal studies: serum vitamin D and prostate cancer risk. Cancer Epidemiol 2009;33:435-45.
5. Albanes D, Mondul AM, Yu K, Parisi D, Horst RL, Virtamo J, et al. Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case- control study. Cancer Epidemiol Biomarkers Prev 2011;20:1850-60.
6. Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 19:2739-45.
7. Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376:180-8.
8. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 2005;16:83-95. (Pubitemid 40691207)
9. Hunter DJ, Riboli E, Haiman CA, Albanes D, Altshuler D, Chanock SJ, et al. A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer 2005;5:977-85.
10. Hiraki LT, Major JM, Chen C, Cornelis MC, Hunter DJ, Rimm EB, et al. Exploring the genetic architecture of circulating 25-hydroxyvitamin D. Genet Epidemiol 2013;37:92-8.
11. Schumacher FR, Berndt SI, Siddiq A, Jacobs KB, Wang Z, Lindstrom S, et al. Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet 2011;20:3867-75.
12. Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, JellumE, Hallmans G, et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 2004;108:104-8. (Pubitemid 37444451)
13. Berndt SI, Dodson JL, Huang WY, Nicodemus KK. A systematic review of vitamin D receptor gene polymorphisms and prostate cancer risk. J Urol 2006;175:1613-23.
14. McCullough ML, Bostick RM, Mayo TL. Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer. Annu Rev Nutr 2009;29:111-32.
15. Shui IM, Mucci LA, Kraft P, Tamimi RM, Lindstrom S, Penney KL, et al. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study. J Natl Cancer Inst 2012;104:690-9.
16. Jorde R, Schirmer H, Wilsgaard T, Joakimsen RM, Mathiesen EB, Njolstad I, et al. Polymorphisms related to the serum 25-hydroxyvitamin d level and risk of myocardial infarction, diabetes, cancer and mortality. The tromso study. PLoS ONE 2012;7:e37295.
17. Ahn J, Albanes D, Berndt SI, Peters U, Chatterjee N, Freedman ND, et al. Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. Carcinogenesis 2009;30:769-76.
18. Holick CN, Stanford JL, Kwon EM, Ostrander EA, Nejentsev S, Peters U. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer. Cancer Epidemiol Biomarkers Prev 2007;16:1990-9. (Pubitemid 47621172)
19. Holt SK, Kwon EM, Peters U, Ostrander EA, Stanford JL. Vitamin D pathway gene variants and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2009;18:1929-33.
20. Beuten J, Gelfond JA, Franke JL, Weldon KS, Crandall AC, Johnson- Pais TL, et al. Single and multigenic analysis of the association between variants in 12 steroid hormone metabolism genes and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2009;18: 1869-80.
21. Kidd LC, Paltoo DN, Wang S, Chen W, Akereyeni F, Isaacs W, et al. Sequence variation within the 50 regulatory regions of the vitamin D binding protein and receptor genes and prostate cancer risk. Prostate 2005;64:272-82. (Pubitemid 40980869)
22. Ioannidis JP, Castaldi P, Evangelou E. A compendium of genome-wide associations for cancer: critical synopsis and reappraisal. J Natl Cancer Inst 2010;102:846-58.
23. Kote-Jarai Z, Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, et al. Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet 2011;43: 785-91.
24. Pittas AG, Dawson-Hughes B. Vitamin D and diabetes. J Steroid Biochem Mol Biol 2010;121:425-9.
25. Albanes D, Weinstein SJ, Wright ME, Mannisto S, Limburg PJ, Snyder K, et al. Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer. J Natl Cancer Inst 2009;101:1272-9.
26. Nimptsch K, Platz EA, Willett WC, Giovannucci E. Association between plasma 25-OH vitamin D and testosterone levels in men. Clin Endocrinol 2012;77:106-12.
27. Pike JW, Feldman D, Glorieux FH. Vitamin D. San Diego,CA: Academic Press; 1997.
28. Speeckaert M, Huang G, Delanghe JR, Taes YE. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta 2006;372:33-42. (Pubitemid 44286753)